文献速递衰弱、肌少症与跌倒老年慢病共病管理

衰弱老年人房颤管理的系统综述与荟萃分析

Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis.
PubMed 文献 · Age Ageing · 2019-01-01

结果显示,房颤患者中衰弱与卒中、全因死亡、症状严重度和住院时长增加相关;衰弱与入院时口服抗凝药处方减少相关,但出院时无显著关联,社区研究中方向相反。

要点

  • 房颤患者中衰弱与卒中、全因死亡、症状严重度和住院时长增加相关。
  • 衰弱与入院时口服抗凝药处方减少相关(汇总校正OR 0.45,95%CI 0.22-0.93)。
  • 衰弱与出院时口服抗凝药处方无显著关联(汇总校正OR 0.40,95%CI 0.13-1.23)。

核心结论

  • 衰弱在房颤患者中常见,且与不良临床结局相关。
  • 衰弱状态与口服抗凝药处方存在关联,但社区与医院队列中效应方向不同。
  • 社区老年人照护占多数,但缺乏该场景下衰弱、房颤、抗凝与临床结局关联的证据。

研究设计与样本

  • 偏倚风险为低至中等。

主要发现

  • 房颤患病率为3%-38%。
  • 房颤患者中,衰弱与卒中发生率、全因死亡率、症状严重度和住院时长增加相关。
  • 六项研究的荟萃分析显示,衰弱与入院时口服抗凝药处方减少相关(汇总校正OR 0.45,95%CI 0.22-0.93,三项研究)。
  • 衰弱与出院时口服抗凝药处方无显著关联(汇总校正OR 0.40,95%CI 0.13-1.23,三项研究)。
  • 一项社区研究显示衰弱与口服抗凝药处方增加相关(OR 2.33,95%CI 1.03-5.23)。

临床怎么用

  • 对房颤合并衰弱的老年人,应关注其卒中、死亡、症状加重和住院时长增加的风险。
  • 衰弱状态可能影响口服抗凝药处方决策,医院与社区场景下的关联方向不同,需结合具体照护环境评估。

局限性

  • 纳入研究均为观察性研究。
  • 社区场景下关于衰弱、房颤、抗凝与临床结局关联的证据缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: despite a large and growing population of older people with frailty and atrial fibrillation (AF), there is a lack of guidance on optimal AF management in this high-risk group. OBJECTIVE: to synthesise the existing evidence base on the association between frailty, AF and clinical outcomes. METHODS: a systematic review of studies examining the association between validated measures of frailty, AF and clinical outcomes, and meta-analysis of the association between frailty and oral anticoagulation (OAC) prescription. RESULTS: twenty studies (30,883 patients) were included, all observational. Fifteen were in hospital, four in the community, one in nursing care. Risk of bias was low-to-moderate. AF prevalence was 3%-38%. In people with AF, frailty was associated with increased stroke incidence, all-cause mortality, symptom severity and length of hospital stay.Meta-analysis of six studies showed frailty was associated with decreased OAC prescription at hospital admission (pooled adjusted OR 0.45 [95%CI 0.22-0.93], three studies), but not at discharge (pooled adjusted OR 0.40 [95%CI 0.13-1.23], three studies). A community-based study showed increased OAC prescription associated with frailty (OR 2.33 [95%CI 1.03-5.23]). CONCLUSION: frailty is common, and associated with adverse clinical outcomes in patients with AF. There is evidence of an association between frailty status and OAC prescription, with different direction of effect in community compared with hospital cohorts. Despite the majority of care for older people being provided in the community, there is a lack of evidence on the association between frailty, AF, anticoagulation and clinical outcomes to guide optimal care in this setting.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Wilkinson C, Todd O, Clegg A, et al. Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing. 2019. PMID: 30445608. doi:10.1093/ageing/afy180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。